Conduent (CNDT) Competitors

Conduent (NASDAQ:CNDT) and GoodRx (NASDAQ:GDRX) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Which has more risk & volatility, CNDT or GDRX?

Conduent has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500. Comparatively, GoodRx has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500.

Is CNDT or GDRX more profitable?

Conduent has a net margin of 8.66% compared to GoodRx's net margin of 3.57%. GoodRx's return on equity of 7.85% beat Conduent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conduent	8.66%	-11.28%	-3.45%
GoodRx	3.57%	7.85%	3.91%

Which has better valuation & earnings, CNDT or GDRX?

Conduent has higher revenue and earnings than GoodRx. Conduent is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conduent	$3.36B	0.13	$426M	$1.37	1.89
GoodRx	$797.41M	2.14	$16.39M	$0.08	59.69

Do analysts prefer CNDT or GDRX?

GoodRx has a consensus price target of $6.55, suggesting a potential upside of 37.08%. Given GoodRx's stronger consensus rating and higher possible upside, analysts plainly believe GoodRx is more favorable than Conduent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conduent	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
GoodRx	0 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.64

Does the media prefer CNDT or GDRX?

In the previous week, GoodRx had 2 more articles in the media than Conduent. MarketBeat recorded 4 mentions for GoodRx and 2 mentions for Conduent. Conduent's average media sentiment score of 1.72 beat GoodRx's score of 0.65 indicating that Conduent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conduent	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
GoodRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders hold more shares of CNDT or GDRX?

77.3% of Conduent shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 3.0% of Conduent shares are owned by company insiders. Comparatively, 4.5% of GoodRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

GoodRx beats Conduent on 10 of the 17 factors compared between the two stocks.